Author: Ying Huang; Rui Yang; Ying Xu; Ping Gong
Title: Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China Document date: 2020_2_29
ID: 9hh17k86_33
Snippet: Thirty-five (35, 97.22%) patients received antiviral treatment, including oseltamivir, ganciclovir, ribavirin or umifenovir hydrochloride. All patients were given antibiotic treatment ( Table 2) Table 2 ). The median time from onset to death was 17 days (Figure 1 )......
Document: Thirty-five (35, 97.22%) patients received antiviral treatment, including oseltamivir, ganciclovir, ribavirin or umifenovir hydrochloride. All patients were given antibiotic treatment ( Table 2) Table 2 ). The median time from onset to death was 17 days (Figure 1 ).
Search related documents:
Co phrase search for related documents- antiviral treatment and death onset median time: 1
- antiviral treatment and median time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- death onset median time and median time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
Co phrase search for related documents, hyperlinks ordered by date